Milestone Pharmaceuticals

Milestone Pharmaceuticals

MIST· Manufacturing· Fiscal year ends in December

CEO pay in FY2024Stock +41.3% in FY2024

Joseph Oliveto is the CEO of Milestone Pharmaceuticals and was paid $882.3K in FY2024 (Dec), down 55%.

Pay$100 in the stock at the end of FY21 → $36
CEO pay is from each Milestone Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1David BharuchaFY2025
  2. 2Amit HasijaFY2025
  3. 3Joseph OlivetoFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Milestone Pharmaceuticals paid its 2 named executives $2.0M in total in FY2025 (Dec).

Name
David BharuchaChief Medical OfficerNot disclosed
Amit HasijaChief Financial Officer and Executive Vice President of Corporate DevelopmentNot disclosedNot disclosed
Joseph OlivetoChief Executive Officer & PresidentNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Milestone Pharmaceuticals. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KMar 20, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 13, 2025FY2024
Proxy statementDEF 14AJul 15, 2024FY2023
Annual report10-KMar 21, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data